PaulaC(Dinkins)HerrmannMDFACP

PubMed

• Physicochemically modified silicon as a substrate for protein microarrays.
  Nijdam, A. J., Ming-Cheng Cheng, M., Geho, D. H., Fedele, R., Herrmann, P., Killian, K., Espina, V., Petricoin, E. F., Liotta, L. A., Ferrari, M.> ;Biomaterials. 2007 Jan
• Cancer proteomics: the state of the art.
  Herrmann, P. C., Liotta, L. A., Petricoin, E. F.> ;Dis Markers. 2001
• Fractionation of serum components using nanoporous substrates.
  Geho, D., Cheng, M. M., Killian, K., Lowenthal, M., Ross, S., Frogale, K., Nijdam, J., Lahar, N., Johann, D., Herrmann, P., Whiteley, G., Ferrari, M., Petricoin, E., L...> ;Bioconjug Chem. 2006 May 01
• Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays.
  Geho, D., Lahar, N., Gurnani, P., Huebschman, M., Herrmann, P., Espina, V., Shi, A., Wulfkuhle, J., Garner, H., Petricoin, E., Liotta, L. A., Rosenblatt, K. P.> ;Bioconjug Chem. 2005 May 19
• Inhibiting platelet-stimulated blood coagulation by inhibition of mitochondrial respiration.
  Barile, C. J., Herrmann, P. C., Tyvoll, D. A., Collman, J. P., Decreau, R. A., Bull, B. S.> ;Proc Natl Acad Sci U S A. 2012 Feb 14
• Mitochondrial proteome: toward the detection and profiling of disease associated alterations.
  Herrmann, P. C., Herrmann, E. C.> ;Methods Mol Biol. 2012
• An algorithm for preventing bypass-associated dilutional (BAD) coagulopathy: Theory and example.
  Herrmann, P. C., Hay, K. L., Bull, B. S.> ;Blood Cells Mol Dis. 2010 Jun 15
• Postoperative bypass bleeding: a bypass-associated dilutional (BAD) coagulopathy?
  Bull, B. S., Hay, K. L., Herrmann, P. C.> ;Blood Cells Mol Dis. 2009 Nov 01
• Oxygen metabolism and a potential role for cytochrome c oxidase in the Warburg effect.
  Herrmann, P. C., Herrmann, E. C.> ;J Bioenerg Biomembr. 2007 Jun
• Non-Hodgkin''s lymphoma in Job''s syndrome: a case report and literature review.
  Leonard, G. D., Posadas, E., Herrmann, P. C., Anderson, V. L., Jaffe, E. S., Holland, S. M., Wilson, W. H.> ;Leuk Lymphoma. 2004 Dec
• Mitochondrial proteome: cancer-altered metabolism associated with cytochrome c oxidase subunit level variation.
  Krieg, R. C., Knuechel, R., Schiffmann, E., Liotta, L. A., Petricoin, E. F., Herrmann, P. C.> ;Proteomics. 2004 Sep
• ProteinChip Array analysis of microdissected colorectal carcinoma and associated tumor stroma shows specific protein bands in the 3.4 to 3.6 kDa range.
  Krieg, R. C., Fogt, F., Braunschweig, T., Herrmann, P. C., Wollscheidt, V., Wellmann, A.> ;Anticancer Res. 2004 Jul 28
• Trapping radioactive carbon dioxide during cellular metabolic assays under standard culture conditions: description of a unique gas-capturing device.
  Krieg, R. C., Liotta, L. A., Petricoin, E. F., Herrmann, P. C.> ;J Biochem Biophys Methods. 2004 Feb 27
• Surrogate tissue analysis: monitoring toxicant exposure and health status of inaccessible tissues through the analysis of accessible tissues and cells.
  Rockett, J. C., Burczynski, M. E., Fornace, A. J., Herrmann, P. C., Krawetz, S. A., Dix, D. J.> ;Toxicol Appl Pharmacol. 2004 Jan 15
• Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.
  Herrmann, P. C., Gillespie, J. W., Charboneau, L., Bichsel, V. E., Paweletz, C. P., Calvert, V. S., Kohn, E. C., Emmert-Buck, M. R., Liotta, L. A., Petricoin, E. F.> ;Proteomics. 2003 Sep
• Join now to see all